Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Pediatric Epilepsy Study [Phase 3]
Novartis-sponsored Phase 3 pediatric epilepsy trial has completed.
-
CLINICAL_TRIALS research · 2011-11-22Clinical Trial Update: EEG Objectification in Neuropsychiatry [NA]
This is a clinical trial update regarding EEG objectification in neuropsychiatry. It lists personality disorder and depression among the stu…
-
FDA approval · 2011-11-17FDA Approved: PRIMIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for Primidone from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-11-17FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)
FDA approved a supplemental application for Levetiracetam from Patrin Pharma, Inc., resulting in a supplemental approval for this generic an…
-
FDA approval · 2011-11-13FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-11-09FDA Approved: LEVETIRACETAM — Original Application (WG Critical Care, LLC)
The FDA approved an original application for levetiracetam from WG Critical Care, LLC.
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy [Phase 3]
A Phase 3 trial evaluating retigabine for partial-onset refractory seizures in epilepsy has completed, with efficacy and safety results post…
-
FDA approval · 2011-11-04FDA Approved: TIAGABINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc. tiagabine hydrochloride tablets as an original generic approval for adjunctive treatmen…
-
FDA approval · 2011-10-30FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Trileptal (oxcarbazepine) from Novartis Pharmaceuticals Corporation to update the product la…
-
FDA approval · 2011-10-30FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2011-10-30FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy [Phase 3]
A Phase 3 trial evaluating retigabine as adjunctive therapy for partial-onset seizures in epilepsy has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects [Phase 1]
Phase 1 study assessing pharmacokinetics and safety/tolerability of lacosamide across three doses in healthy male Korean volunteers.
-
FDA approval · 2011-10-13FDA Approved: LEVETIRACETAM — Original Application (Civica, Inc.)
The FDA approved Civica, Inc.'s original application for a generic levetiracetam product. This approval provides a generic version of leveti…
-
CLINICAL_TRIALS research · 2011-10-12Clinical Trial Update: Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy [Phase 2]
This clinical trial update describes a Phase 2 study investigating the effects of physical exercise in individuals with juvenile myoclonic e…
-
FDA approval · 2011-10-06FDA Approved: LAMOTRIGINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved Unichem Pharmaceuticals (USA), Inc.'s original application for lamotrigine, making a generic version available for treatmen…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
The FDA approved a supplemental application for the Lamotrigine Kit from OWP Pharmaceuticals, Inc., authorizing a supplemental marketing use…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lamotrigine filed by Zydus Pharmaceuticals USA Inc. The approval indicates changes under the…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited under ANDA090401.
-
FDA approval · 2011-09-29FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Gabapentin submitted by BluePoint Laboratories.
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine by Dr. Reddy's Laboratories Limited (ANDA076708), indicating a change related to the…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-09-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
-
FDA approval · 2011-09-27FDA Approved: ZONISAMIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for zonisamide submitted by Viona Pharmaceuticals, indicating approval of changes to the product.
-
FDA approval · 2011-09-23FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)
FDA records an approval supplement for Zonegran (zonisamide) submitted by Advanz Pharma (US) Corp.